key: cord-0878055-taqwkloq
authors: Costa, Rosa; Bueno, Felipe; Albert, Eliseo; Torres, Ignacio; Carbonell-Sahuquillo, Silvia; Barrés-Fernández, Ana; Sánchez, David; Padrón, Carmelo; Colomina, Javier; Lázaro Carreño, María Isabel; Bretón-Martínez, José Rafael; Martínez-Costa, Cecilia; Navarro, David
title: Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults
date: 2021-08-09
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.08.001
sha: f369d3d4f93c30115710d16427115659b2a37b61
doc_id: 878055
cord_uid: taqwkloq

OBJECTIVES: Studies comparing SARS-CoV-2 RNA load in the upper respiratory tract (URT) between children and adults, either presenting with COVID-19 or asymptomatic have yielded inconsistent results. Here, we conducted a retrospective, single center study to address this issue. PATIENTS AND METHODS: 1,184 consecutive subjects (256 children and 928 adults) testing positive for SARS-COV-2 RNA in nasopharyngeal exudates (NP), of whom 424 (121 children and 303 adults) had COVID-19 and 760 (135 children and 625 adults) were asymptomatic close contacts of COVID-19 patients. SARS-CoV-2 RNA testing was carried out using the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MS, USA). The AMPLIRUN® TOTAL SARS-CoV-2 RNA Control (Vircell SA, Granada, Spain) was used for estimating SARS-CoV-2 RNA loads (in copies/mL). SARS-CoV-2 RNA loads at the time of laboratory diagnosis (single specimen/patient) were used for comparison purposes. RESULTS: Median initial SARS-COV-2 RNA load was lower (P=0.094) in children (6.98 log(10) copies/ml; range, 3.0-11.7) than in adults (7.14 log(10) copies/ml; range, 2.2.-13.4) with COVID-19. As for asymptomatic individuals, median SARS-CoV-2 RNA load was comparable (P=0.97) in children (6.20 log(10) copies/ml; range, 1.8-11.6) and adults (6.48 log(10) copies/ml; range, 1.9-11.8). Children with COVID-19 symptoms displayed SARS-CoV-2 RNA loads (6.98 log(10) copies/ml; range, 3.0-11.7) comparable to their asymptomatic counterparts (6.20 log(10) copies/ml; range, 1.8-11.6) (P=0.61). Meanwhile in adults, median SARS-CoV-2 RNA load was significantly higher in symptomatic (7.14 log(10) copies/ml; range, 2.2.-13.4) than in asymptomatic subjects (6.48 log(10) copies/ml; range, 1.9-11.8) (P=<0.001). Overall, a faster URT SARS-CoV-2 RNA clearance rate was observed in children than in adults. CONCLUSIONS: Based on viral load data at the time of diagnosis, our results suggested that SARS-CoV-2 infected children, with or without COVID-19, may display NP viral loads of comparable magnitude to that found in their adult counterparts; However, children may have shorter viral shedding as compared to adults.

An increasing body of evidence suggests that children are less susceptible to SARS-57

CoV-2 infection and tend to develop milder forms of COVID-19 than adults [1] . 58

Nevertheless, whether children, either symptomatic or asymptomatic, play a major role 59 in community transmission of SARS-CoV-2 compared to adults remains unclear [1] . 60

There is a consistent direct correlation between magnitude of SARS-CoV-2 RNA load 61 in the upper respiratory tract (URT) probability of recovering live virus in cell culture, 62 and contagiousness in both adults and children [2] [3] [4] [5] . Supporting this assumption, 63 transmission risk was recently shown to be strongly associated with initial SARS-CoV-64 2 RNA levels of index cases [6] . There is contradictory information on how SARS-65

CoV-2 RNA load in URT compares between children and adults [7] [8] [9] [10] [11] , whether viral 66 load in pediatric subjects differ across ages [9,10], and whether dissimilarities in the 67 dynamics of SARS-CoV-2 shedding in URT exist between symptomatic and 68 asymptomatic children [12] [13] [14] . Elucidation of these questions is one important piece of 69 trying to establish the relative transmission risk between adults and children, although it 70 should be kept in mind that in addition to URT viral load, other factors such as the 71 ability to release aerosols, the nature of symptoms and social mixing patterns may 72 modulate contagiousness. Here, to gain a further insight into these issues, we conducted Viral/Pathogen II Nucleic Acid Isolation Kits coupled with Thermo Scientific™ 100

KingFisher Flex automated instrument. The AMPLIRUN® TOTAL SARS-CoV-2 101 RNA Control (Vircell SA, Granada, Spain) was used as the reference material for 102 estimating SARS-CoV-2 RNA load (in copies/mL, taking RT-PCR CTs for the N gene) 103 [16, 17] . 104

We amplified the β-glucuronidase (GUSB) housekeeping gene to assess specimen 106 cellularity in selected specimens following a previously published protocol [18] presented with symptoms compatible with COVID-19. Specimen collection was carried 125 out at a median of 2 days (range, 0-10 days) and a median of 3 days (range, 0-10 days), 126 after symptoms onset in children and adults, respectively. A total of 760 participants 127 (135 children and 625 adults) were close contacts of COVID-19 patients and 128 asymptomatic at the time of testing positive by RT-PCR for the first time. No 129 information was available on our database regarding whether these latter individuals 130

were household or non-household contacts or whether or not they developed symptoms 131 later on. NP specimen collection in contacts was prescribed at the discretion of either 132 the physician in charge of the index case or local health authorities, and was performed 133 at a median of 7 days (range, 1-10 days) after diagnosis of the presumed index case, 134 both in children and adults. Initial SARS-CoV-2 RNA loads were used throughout the 135 current study for comparison purposes. 136

We first compared initial SARS-CoV-2 RNA load in NP from symptomatic pediatric 138 and adult patients. The data are shown in Fig. 1A . The range of SARS-COV-2 RNA 139 loads appeared comparable between children and adults. Median viral RNA load in 140 children (6.98 log10 copies/ml) was lower than that in adults (7.14 log10 copies/ml), 141 although the difference did not reach statistical significance (P=0.094). 142

We next compared initial SARS-CoV-2 RNA load in children and adults by time of NP 143 sampling after symptoms onset. SARS-CoV-2 RNA load peaks soon after or at the time (within 2 days/≥3 days after symptoms onset). SARS-CoV-2 RNA load was 147 significantly higher in NP specimens collected within 2 days after onset of symptoms 148 than in those obtained later on, in both children (median, 7.46 log10 copies/ml vs. 5.17 149 log10 copies/ml; P=<0.001) and adults (7.81 log10 copies/ml vs. 6.45 log10 copies/ml; 150 P=0.002) (Fig. 2) . Interestingly, SARS-CoV-2 RNA load measured within 2 days after 151 symptoms onset was comparable (P=0.26) between children and adults, whereas those 152 determined at later times (≥3 days) were significantly lower in children (P=0.002). 153

Finally, as shown in Figure 3 A and B, no correlation was found between initial SARS-154 

A wide range of SARS-CoV-2 RNA loads were detected in asymptomatic children and 159 adults (Fig. 4) . SARS-CoV-2 RNA loads in asymptomatic children (median, 6.20 log10 160 copies/ml) and adults (6.48 log10 copies/ml) were comparable in magnitude (P=0.97). 161

Moreover, no correlation was found between age and SARS-CoV-2 load (Rho, 0.066; 162 P=0.44 for children and Rho, 0.020; P=0.62 for adults) ( Fig. 3C and 3D ). 163

Children with COVID-19 symptoms displayed slightly higher SARS-CoV-2 RNA load 166 than their asymptomatic counterparts (Fig. 5A ), although statistical significance was not 167 reached (P=0.61). In adults, median estimated SARS-CoV-2 RNA load was virions 171

We previously reported that SARS-CoV-2 could not be cultured from NP specimens 172 returning CT >25 (<5.9 log10 copies/ml) by the TaqPath COVID-19 RT-PCR [16] . We 173 investigated the distribution of specimens yielding CT <25 across children and adults. 174

The data are shown in Supplementary Fig. 1 . Overall, the percentage of NP specimens 175 returning SARS-CoV-2 N RT-PCR CTs below the abovementioned threshold was 176 similar for symptomatic children and adults (P=0.28) and was also comparable between 177 asymptomatic children and adults (P=0.87). Among children, that percentage was 178 higher for those aged under 3 years although the difference was not statistically 179 significant (P=0.22). For most age groups the percentage was higher in symptomatic 180 than in asymptomatic subjects, although these differences did not reach statistical 181 significance (P>0.5). 182

participants 184

To assess the quality of NP specimens collected from children and adults regarding 185 cellularity, we randomly selected 30 samples from each population group (n=60) that 186 were matched in SARS-CoV-2 RNA load (median 5.70 log10 copies/ml; range 3.5-11.6 187 log10 copies/mL in specimens from children; median, 6.60 log10 copies/ml; range, 2. develop in children compared to adults), lung capacity and the ability to release 217 aerosols, which seems to be lower in children than in adults, in particular in the absence 218 of symptoms [24], as well as differential social contacts and mixing patterns. In fact, a 219 recent Danish study suggested an stronger correlation between age and transmission risk 220 than that between the CT value and transmissibility [25] . Furthermore, our finding that 221 SARS-CoV-2 clearance in the URT may proceed at a faster rate in children compared to 222 adults gives further support to this argument. 223

Second, pairwise comparison analyses revealed no significant differences in SARS-224

CoV-2 RNA load across age groups, in either symptomatic children or adults; in 225 children, a similar conclusion can be derived from the study by Kociolek Kociolek's the authors admit a potential population bias towards lower SARS-CoV-2 257 loads due to an excessive number of remote infections (>10 days) detected via screening 258 programs (i.e. hospital pre-admission). 259

Like the majority of commercially-available SARS-CoV-2 RT-PCRs, the RT-PCR 260 assays used in the current study do not co-amplify a housekeeping gene, thus precluding 261 assessment of sample cellularity. Given the widely varying quality of NP specimens 262 [18] which impacts significantly on estimated SARS-VoV-2 RNA loads [36], we 263 compared a randomly selected set of NP specimens from children and adults for their 264 cellular content using a housekeeping-gene RT-PCR set in parallel. We found 265 overlapping CTs in samples from both subject groups, making it unlikely that 266 differences in cellularity had a major impact on our results. However, only a small 267 number of NP specimens were screened for their cellular content. 268

The current study has several limitations. First, dissimilarities in the timing of NP 269 collection across symptomatic and asymptomatic individuals may have blurred true 270 differences in SARS-CoV-2 RNA load across groups. While the kinetics of SARS-271

CoV-2 RNA load in URT has been clearly established in symptomatic individuals, with 272 viral load peaking around the time of symptoms onset [19] , it remains to be precisely 273 characterized in asymptomatic subjects. In fact, a population bias of this cohort towards 274 higher viral loads in the asymptomatic population group in the current study cannot be 275 

Susceptibility 304 to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A 305 Systematic Review and Meta-analysis

Virological assessment of hospitalized patients with COVID-2019

Culture-based virus 310 isolation to evaluate potential infectivity of clinical specimens tested for COVID-19. J 11

Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and 339

Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital 340

Testing Programs

Clinical 342 Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in 343 the Republic of Korea

CoV-2 viral RNA load dynamics in the nasopharynx of infected children

Estrategia de detección precoz

mentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf

Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for

COVID-19 diagnosis in primary healthcare centres

Evaluation of a rapid antigen 356 test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in 357

Amplification of 360 human beta-glucuronidase gene for appraising the accuracy of negative SARS

RT-PCR results in upper respiratory tract specimens

viral load dynamics, duration of viral shedding, and 365 infectiousness: a systematic review and meta-analysis

Epidemiology and transmission of

COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a 368 retrospective cohort study

COVID-19 in children: the link in the transmission chain

Transmission of SARS-CoV-2 infection among children in summer schools applying 373 stringent control measures in

Children are not COVID-19 super spreaders: time to go back 375 to school

SARS-CoV-2 Viral

Load in Upper Respiratory Specimens of Infected Patients

Asymptomatic transmission during the COVID-19 pandemic 386 and implications for public health strategies

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

The role of 391 asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living 392 systematic review

-2 infections: A living systematic review and meta-analysis

Household 398 transmission of SARS-CoV-2 and risk factors for susceptibility

400 symptomatic and symptomatic transmission risk of SARS-CoV-2

Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV

Infection in a Community Treatment Center in the Republic of Korea

Upper respiratory viral load in 408 asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 409 infection

SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus

Exposed Kids (BRAVE Kids) Study

patients in each group as well as P values for comparisons between groups (median 450 SARS-CoV-2 RNA levels) are shown

Supplementary Figure 3. Initial SARS-CoV-2 RNA loads in nasopharyngeal 452 specimens from asymptomatic individuals across different pediatric and adult ages

Whiskers indicate the upper and lower values. The number of 455 patients in each group as well as P values for comparisons between groups